1.	Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 75 Sponsor: NCI Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
2.	Diindolylmethane in Treating Patients With Breast Cancer Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689
3.	Omega 3 FA Supplements as Augmentation in the Treatment of Depression Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OmegaDVS, NCT01803711
4.	Selenium for Prevention of Adenomatous Colorectal Polyps Phase: Phase III Type: Prevention Status: Active Age: 40 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000353185, P30CA023074, UARIZ-00-0430-01, UARIZ-HSC-00142, P01CA041108, 00-0430-01, NCT00078897
5.	Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 9218, NCT00212381
6.	Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0309006308, NCT00195013
7.	Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SV-001 and SV-002, SFC-SV001, SFC-01-0150-0001-02-CM, SFC-01-0150-001, SFC-SV002, NCT00246727
8.	S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 Phase: Phase III Type: Natural history/Epidemiology, Prevention Status: Active Age: 50 and over Sponsor: NCI, Other Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121
9.	The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients Phase: Phase III Type: Supportive care Status: Active Age: 1 to 21 Sponsor: Other Protocol IDs: 06-08-367, NCT00726934
10.	Vitamin D and Omega-3 Trial (VITAL) Phase: Phase III Type: Prevention Status: Active Age: 60 and over Sponsor: NCI, Other Protocol IDs: 2009P-001217, NCT01169259
11.	Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Phase: Phase III Type: Treatment Status: Active Age: 18 to 72 Sponsor: Pharmaceutical / Industry Protocol IDs: CS001P3, 2010-019952-35, NCT01265849
12.	Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 68905, RPCI-I-68905, NCT00536991
13.	A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0706002781, ACS IRG 58-012-49, NCT00730158
14.	Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000642377, OSU-2007C0026, 2007C0026, NCT01009736
15.	Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral ß-glucan for High-Risk Neuroblastoma Phase: Phase II, Phase I Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: 05-075, NCT00911560
16.	Vitamin D - Celecoxib Therapy Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: CLIN-003-09S, NCT00953849
17.	Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-01434, NCI09-13-02, CDR0000671302, N01CN03515, NU-NWU09-13-02, NWU09-13-02, NCT01111292
18.	Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NUALA-01, STU00041525, NCT01313117
19.	Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J1161, NCT01317199
20.	Saw Palmetto: Symptom Management for Men During Radiation Therapy Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: Application ID 213, NCT01585246
21.	A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective Phase: Phase II, Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 12D.424, NCT01754987
22.	Boswellia serrata and Standard Treatment or Standard Treatment Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed or Recurrent High-Grade Glioma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CASE-CCF-7348, CCF-7348, NCT00243022, CASE1304200
23.	Folic Acid Clinical Trial for the Prevention of Cervical Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196
24.	Trial of Aspirin and Arginine Restriction in Colorectal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: UCI 07-47, NCT00578721
25.	Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Germanium, NCT00651417